[Evaluation of the effectiveness of Uro-Vaxom in recurrent urinary tract infections in children].
The aim of the study was to determine the effectiveness of Uro-Vaxom in the treatment in children with recurrent urinary tract infections induced by E. coli. Our investigations confirmed that in the group of children receiving pharmacotherapy and Uro-Vaxom, a significant increase of sIgA in the urine was found, lasting for at least 3 months. During this period no infection appeared in 92% of the examined children. The authors recommend including Uro-Vaxom in the therapy of children, because it is effective and well-tolerated by children.
Czerwionka-Szaflarska
M
M
Katedra i Klinika Gastroenterologii i Chorób Dzieci Akademii Medycznej w Bydgoszczy.
Pawłowska
M
M
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004926:Escherichia coli; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000652:urine; D008297:Male; D012008:Recurrence; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D007070:Immunoglobulin A